Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.180
+0.070 (6.31%)
Aug 14, 2025, 11:31 AM - Market open
Lexicon Pharmaceuticals Employees
Lexicon Pharmaceuticals had 103 employees as of December 31, 2024. The number of employees decreased by 182 or -63.86% compared to the previous year.
Employees
103
Change (1Y)
-182
Growth (1Y)
-63.86%
Revenue / Employee
$567,301
Profits / Employee
-$1,171,068
Market Cap
428.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LXRX News
- 7 days ago - Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Lexicon Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 14 days ago - Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 22 days ago - Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 27 days ago - Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025) - GlobeNewsWire
- 7 weeks ago - Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewsWire
- 2 months ago - Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewsWire
- 2 months ago - Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire